Suneel Mundle

4PUBLICATIONS
34CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 28, 2024
Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU.

Yoshitaka Honma, Nobuya Monden, Keisuke Yamazaki

|Jun 28, 2024
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study: ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy.

Axel S Merseburger, Neeraj Agarwal, Anders Bjartell

|Apr 15, 2024
Population-based study of disease trajectory after radical treatment for high-risk prostate cancer.

Pär Stattin, Sarah Fleming, Xiwu Lin

|Apr 29, 2021
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study.

Kim N Chi, Simon Chowdhury, Anders Bjartell

Pageof 1

Frequent Collaborators

2 joint publications

Anders Bjartell

1 joint publications

Kim N Chi

1 joint publications

Byung Ha Chung

1 joint publications

Andrea J Pereira de Santana Gomes